Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 MAD Study of TMP-301 in Healthy Subjects
NCT06025396Phase 1Completed
- Sponsor
- Tempero Bio
- Start
- Jan 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cocaine use disorder (CUD) and substance use disorder (SUD) comparing Active TMP-301 with Placebo (2 arms). Primary endpoint: Number of Treatment-Emergent Adverse Events. Started Jan 2023; status: completed.
02
Drugs
TMP-301
03
Conditions
cocaine use disorder (CUD)substance use disorder (SUD)
Beyond the preview
Go deeper on NCT06025396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025396.